The FDA previously approved Dupixent in May 2022 to treat eosinophilic esophagitis in patients aged 12 years and older.
Beyond the Ordinary Beyond the Obvious
Beyond the Ordinary Beyond the Obvious
The FDA previously approved Dupixent in May 2022 to treat eosinophilic esophagitis in patients aged 12 years and older.
